Literature DB >> 21571973

Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations.

J T Galea1, J J Kinsler, X Salazar, S-J Lee, M Giron, J N Sayles, C Cáceres, W E Cunningham.   

Abstract

This study examined pre-exposure prophylaxis (PrEP) acceptability among female sex workers, male-to-female transgendered persons and men who have sex with men in Lima, Peru. Focus groups explored social issues associated with PrEP acceptability and conjoint analysis assessed preferences among eight hypothetical PrEP scenarios with varying attribute profiles and their relative impact on acceptability. Conjoint analysis revealed that PrEP acceptability ranged from 19.8 to 82.5 out of a possible score of 100 across the eight hypothetical PrEP scenarios. Out-of-pocket cost had the greatest impact on PrEP acceptability (25.2, P < 0.001), followed by efficacy (21.4, P < 0.001) and potential side-effects (14.7, P < 0.001). Focus group data supported these findings, and also revealed that potential sexual risk disinhibition, stigma and discrimination associated with PrEP use, and mistrust of health-care professionals were also concerns. These issues will require careful attention when planning for PrEP roll-out.

Entities:  

Mesh:

Year:  2011        PMID: 21571973      PMCID: PMC3096991          DOI: 10.1258/ijsa.2009.009255

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  31 in total

1.  Partner notification for sexually transmitted diseases in Peru: knowledge, attitudes, and practices in a high-risk community.

Authors:  Jesse L Clark; Corey M Long; Jessica M Giron; Julio A Cuadros; Carlos F Caceres; Thomas J Coates; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2007-05       Impact factor: 2.830

2.  Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events, 2004.

Authors:  Scott E Kellerman; Angela B Hutchinson; Elin B Begley; Brian C Boyett; Hollie A Clark; Patrick Sullivan
Journal:  J Acquir Immune Defic Syndr       Date:  2006-11-01       Impact factor: 3.731

Review 3.  Risk compensation: the Achilles' heel of innovations in HIV prevention?

Authors:  Michael M Cassell; Daniel T Halperin; James D Shelton; David Stanton
Journal:  BMJ       Date:  2006-03-11

4.  One step forward, two steps back--will there ever be an AIDS vaccine?

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2007-12-27       Impact factor: 91.245

5.  Willingness to participate in HIV vaccine trials: the impact of trial attributes.

Authors:  Peter A Newman; Naihua Duan; Sung-Jae Lee; Ellen Rudy; Danielle Seiden; Lisa Kakinami; William Cunningham
Journal:  Prev Med       Date:  2006-12-24       Impact factor: 4.018

Review 6.  Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1.

Authors:  Myron S Cohen; Cynthia Gay; Angela D M Kashuba; Sally Blower; Lynn Paxton
Journal:  Ann Intern Med       Date:  2007-04-17       Impact factor: 25.391

7.  Prevalences, genotypes, and risk factors for HIV transmission in South America.

Authors:  Silvia M Montano; Jose L Sanchez; Alberto Laguna-Torres; Paloma Cuchi; Maria M Avila; Mercedes Weissenbacher; Margarita Serra; Jose Viñoles; Jose C Russi; Nicolas Aguayo; Adolfo H Galeano; Alberto Gianella; Ronald Andrade; Anabella Arredondo; Eugenio Ramirez; Maria E Acosta; Aracely Alava; Orlando Montoya; Angel Guevara; Hugo Manrique; Jorge L Sanchez; Javier R Lama; Fernando de la Hoz; Gloria I Sanchez; Claudia Ayala; Maria E Pacheco; Gladys Carrion; Gloria Chauca; Juan J Perez; Monica Negrete; Kevin L Russell; Christian T Bautista; James G Olson; Douglas M Watts; Deborah L Birx; Jean K Carr
Journal:  J Acquir Immune Defic Syndr       Date:  2005-09-01       Impact factor: 3.731

8.  Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men.

Authors:  Albert Y Liu; Pravina V Kittredge; Eric Vittinghoff; H Fisher Raymond; Katherine Ahrens; Tim Matheson; Jennifer Hecht; Jeffrey D Klausner; Susan P Buchbinder
Journal:  J Acquir Immune Defic Syndr       Date:  2008-02-01       Impact factor: 3.731

9.  Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback.

Authors:  N Nodin; A Carballo-Diéguez; A M Ventuneac; I C Balan; R Remien
Journal:  AIDS Care       Date:  2008-01

10.  Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings.

Authors:  Ume L Abbas; Roy M Anderson; John W Mellors
Journal:  PLoS One       Date:  2007-09-19       Impact factor: 3.240

View more
  89 in total

Review 1.  How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores".

Authors:  Sarah K Calabrese; Kristen Underhill
Journal:  Am J Public Health       Date:  2015-08-13       Impact factor: 9.308

2.  Venue-Based HIV-Testing: An Effective Screening Strategy for High-Risk Populations in Lima, Peru.

Authors:  Lao-Tzu Allan-Blitz; M Christina Herrera; Gino M Calvo; Silver K Vargas; Carlos F Caceres; Jeffrey D Klausner; Kelika A Konda
Journal:  AIDS Behav       Date:  2019-04

3.  Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: Perspectives of PrEP users and high-risk PrEP naïve men.

Authors:  S Wade Taylor; Kenneth H Mayer; Steven M Elsesser; Matthew J Mimiaga; Conall O'Cleirigh; Steven A Safren
Journal:  AIDS Behav       Date:  2014-05

4.  The Loss of Boystown and Transition to Online Sex Work: Strategies and Barriers to Increase Safety Among Men Sex Workers and Clients of Men.

Authors:  Elena Argento; Matthew Taylor; Jody Jollimore; Chrissy Taylor; James Jennex; Andrea Krusi; Kate Shannon
Journal:  Am J Mens Health       Date:  2016-06-28

5.  The impact of rapid HIV home test use with sexual partners on subsequent sexual behavior among men who have sex with men.

Authors:  Iván C Balán; Alex Carballo-Diéguez; Timothy Frasca; Curtis Dolezal; Mobolaji Ibitoye
Journal:  AIDS Behav       Date:  2014-02

6.  Distinguishing hypothetical willingness from behavioral intentions to initiate HIV pre-exposure prophylaxis (PrEP): Findings from a large cohort of gay and bisexual men in the U.S.

Authors:  H Jonathon Rendina; Thomas H F Whitfield; Christian Grov; Tyrel J Starks; Jeffrey T Parsons
Journal:  Soc Sci Med       Date:  2016-11-18       Impact factor: 4.634

7.  A Qualitative Assessment of Alcohol Consumption and Sexual Risk Behaviors Among Men Who Have Sex With Men and Transgender Women in Peru.

Authors:  Panagiotis Vagenas; Shan-Estelle Brown; Jesse L Clark; Kelika A Konda; Javier R Lama; Jorge Sánchez; Ann C Duerr; Frederick L Altice
Journal:  Subst Use Misuse       Date:  2017-02-07       Impact factor: 2.164

8.  Perceived Advantages and Disadvantages of Using Pre-Exposure Prophylaxis (PrEP) among Sexually Active Black Women: An Exploratory Study.

Authors:  Keosha T Bond; Alana J Gunn
Journal:  J Black Sex Relatsh       Date:  2016

Review 9.  Acceptability in microbicide and PrEP trials: current status and a reconceptualization.

Authors:  Barbara S Mensch; Ariane van der Straten; Lauren L Katzen
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

10.  Preexposure prophylaxis for adolescents and young adults at risk for HIV infection: is an ounce of prevention worth a pound of cure?

Authors:  Jill E Pace; George K Siberry; Rohan Hazra; Bill G Kapogiannis
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.